These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 31142331)

  • 1. The role of patient organizations in the rare disease ecosystem in India: an interview based study.
    Choudhury MC; Saberwal G
    Orphanet J Rare Dis; 2019 May; 14(1):117. PubMed ID: 31142331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The work, goals, challenges, achievements, and recommendations of orphan medicinal product organizations in India: an interview-based study.
    Choudhury MC; Saberwal G
    Orphanet J Rare Dis; 2019 Nov; 14(1):241. PubMed ID: 31684990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The urgent need to empower rare disease organizations in China: an interview-based study.
    Li X; Lu Z; Zhang J; Zhang X; Zhang S; Zhou J; Li B; Ou L
    Orphanet J Rare Dis; 2020 Oct; 15(1):282. PubMed ID: 33046132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The management of rare disease patients from a grassroot perspective: the role of patients' organizations in the global recognition of rare diseases in Cameroon.
    Ngoumou RD; Feudjio YBD
    Pan Afr Med J; 2024; 47():64. PubMed ID: 38681114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A survey of awareness of diagnosis and treatment of rare diseases among healthcare professionals and researchers in India.
    Vashishta L; Bapat P; Bhattacharya Y; Choudhury MC; Chirmule N; D'Costa S; Jindani S; Rao M; Sheth S
    J Biosci; 2023; 48():. PubMed ID: 37795705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rare Diseases in Europe: from a Wide to a Local Perspective.
    Baldovino S; Moliner AM; Taruscio D; Daina E; Roccatello D
    Isr Med Assoc J; 2016 Jun; 18(6):359-63. PubMed ID: 27468531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrating rare disease management in public health programs in India: exploring the potential of National Health Mission.
    Choudhury MC; Chaube P
    Orphanet J Rare Dis; 2022 Feb; 17(1):43. PubMed ID: 35144652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pooling of manpower and resources through the establishment of European reference networks and rare disease patient registries is a necessary area of collaboration for rare renal disorders.
    Parker S
    Nephrol Dial Transplant; 2014 Sep; 29 Suppl 4():iv9-14. PubMed ID: 25165190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health-related quality of life among adults with diverse rare disorders.
    Bogart KR; Irvin VL
    Orphanet J Rare Dis; 2017 Dec; 12(1):177. PubMed ID: 29212508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prioritization of research engaged with rare disease stakeholders: a systematic review and thematic analysis.
    Yoon S; Lee M; Jung HI; Khan MM; Kim SY; Kim H; Wasti S
    Orphanet J Rare Dis; 2023 Nov; 18(1):363. PubMed ID: 37996931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PERSPECTIVES: Mental Health Policy in India: Seven Sets of Questions and Some Answers.
    Mirza A; Singh N
    J Ment Health Policy Econ; 2019 Mar; 22(1):25-37. PubMed ID: 30991353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rare diseases in Tanzania: a National Call for Action to address policy and urgent needs of individuals with rare diseases.
    Kaywanga F; Alimohamed MZ; David AB; Maeda D; Mbarak S; Mavura T; Nkya S; Ishengoma DS
    Orphanet J Rare Dis; 2022 Sep; 17(1):343. PubMed ID: 36064429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancing Equitable Access to Rare Disease Diagnosis and Treatment around the World: A Review of Evidence, Policies, and Challenges.
    Adachi T; El-Hattab AW; Jain R; Nogales Crespo KA; Quirland Lazo CI; Scarpa M; Summar M; Wattanasirichaigoon D
    Int J Environ Res Public Health; 2023 Mar; 20(6):. PubMed ID: 36981643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expansion of India's national child healthcare programme, Rashtriya Bal Swasthya Karyakram (RBSK), for rare disease management : a health policy perspective.
    Chaube P; Singh AK; Choudhury MC
    Orphanet J Rare Dis; 2023 Jun; 18(1):145. PubMed ID: 37308899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A questionnaire-based study to comprehensively assess the status quo of rare disease patients and care-givers in China.
    Li X; Liu M; Lin J; Li B; Zhang X; Zhang S; Lu Z; Zhang J; Zhou J; Ou L
    Orphanet J Rare Dis; 2021 Jul; 16(1):327. PubMed ID: 34294091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rare disease emerging as a global public health priority.
    Chung CCY; ; Chu ATW; Chung BHY
    Front Public Health; 2022; 10():1028545. PubMed ID: 36339196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AIDS in India: constructive chaos?
    Chatterjee A
    Health Millions; 1991 Aug; 17(4):20-3. PubMed ID: 12284225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Policies and actions to tackle rare diseases at European level.
    Montserrat A; Taruscio D
    Ann Ist Super Sanita; 2019; 55(3):296-304. PubMed ID: 31553326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a pilot rare disease registry: a focus group study of initial steps towards the establishment of a rare disease ecosystem in Slovenia.
    Stanimirovic D; Murko E; Battelino T; Groselj U
    Orphanet J Rare Dis; 2019 Jul; 14(1):172. PubMed ID: 31288838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The patient experience of patient-centered communication with nurses in the hospital setting: a qualitative systematic review protocol.
    Newell S; Jordan Z
    JBI Database System Rev Implement Rep; 2015 Jan; 13(1):76-87. PubMed ID: 26447009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.